Organ support & nutrition

Early detection of oliguric events in critically ill patients in the ICU with a novel continuous urine flow measurement device: results of an initial validation study

J Clin Monit ComputPublished Prospective observational validation study

Performance · Agreement of urine flow, Serenno vs Camera (Bland-Altman)Result — go to the resultbias −0.4 ml/h 95% CI - 28 to 27

Authors' conclusion

The Serenno Medical Automatic urine output measuring device required minimal supervision, little ICU nursing staff attention, and is sufficiently accurate and precise. In addition to providing continuous assessments of urine output, it was considerably more accurate than hourly nursing assessments.

Study context

Population
Critically ill ICU patientscompleted the study
Participants
37 patients
Comparison
Serenno automatic urine output device vs camera-read standard urometer
Outcome
Difference between urine flow by the Serenno device and camera-derived measurements
Follow-up
1 to 7 days
Methodological detailsmulticentre (three ICUs)
  • Multicentre (three ICUs)

Performance

As reported in the abstract

Agreement of urine flow, Serenno vs Camera (Bland-Altman)

bias

−0.4 ml/h

95% CI - 28 to 27

Concordance
92%

Secondary outcomes

OutcomeBias (ml)
Agreement of urine output, Camera vs NurseLimits of agreement - 75 to + 107 ml; distinctly worse7.2

Severe oliguria (urine output < 0.3 ml/kg/h) lasting ≥2 h

Patients with severe oliguria
8 (21%)

Severe oliguric events lasting >3 consecutive hours not detected or documented by nursing staff

Undetected events
6 (41%)

Safety

Device-related complications
0

Original publication

Early detection of oliguric events in critically ill patients in the ICU with a novel continuous urine flow measurement device: results of an initial validation study. J Clin Monit Comput. Published 7 April 2023. doi:10.1007/s10877-023-00991-w

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.